AdvisorShares Investments LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AdvisorShares Investments LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q2 2021$877,000
-9.4%
479,453
-2.4%
0.12%
-0.8%
Q1 2021$968,000
+184.7%
491,126
+80.6%
0.12%
+53.2%
Q4 2020$340,000
-32.5%
271,873
-2.8%
0.08%
+229.2%
Q3 2020$504,000
-68.4%
279,671
+47.3%
0.02%
-96.5%
Q2 2020$1,593,000
-3.7%
189,814
-39.9%
0.68%
-52.9%
Q1 2020$1,655,000
-20.4%
315,889
-17.0%
1.44%
+11.1%
Q4 2019$2,079,000380,7501.29%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders